• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

暴露前抗体预防可保护猕猴免受严重流感感染。

Pre-exposure antibody prophylaxis protects macaques from severe influenza.

作者信息

Kanekiyo Masaru, Gillespie Rebecca A, Cooper Kristine, Canedo Vanessa Guerra, Castanha Priscila M S, Pegu Amarendra, Yang Eun Sung, Treaster Luke, Yun Gabin, Wallace Megan, Kettenburg Gwenddolen, Williams Connor, Lundy Jeneveve, Barrick Stacey, O'Malley Katherine, Midgett Morgan, Martí Michelle M, Chavva Hasitha, Corry Jacqueline, Treat Benjamin R, Lipinski Abby, Batsche Lucia Ortiz, Creanga Adrian, Ritter Isabella, Walker Reagan, Olsen Emily, Laughlin Amanda, Perez Daniel R, Mascola John R, Boritz Eli A, Loo Yueh-Ming, Blair Wade, Esser Mark, Graham Barney S, Reed Douglas S, Barratt-Boyes Simon M

机构信息

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Biostatistics Facility, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

Science. 2025 Jan 31;387(6733):534-541. doi: 10.1126/science.ado6481. Epub 2025 Jan 30.

DOI:10.1126/science.ado6481
PMID:39883776
Abstract

Influenza virus pandemics and seasonal epidemics have claimed countless lives. Recurrent zoonotic spillovers of influenza viruses with pandemic potential underscore the need for effective countermeasures. In this study, we show that pre-exposure prophylaxis with broadly neutralizing antibody (bnAb) MEDI8852 is highly effective in protecting cynomolgus macaques from severe disease caused by aerosolized highly pathogenic avian influenza H5N1 virus infection. Protection was antibody dose-dependent yet independent of Fc-mediated effector functions at the dose tested. Macaques receiving MEDI8852 at 10 milligrams per kilogram or higher had negligible impairment of respiratory function after infection, whereas control animals were not protected from severe disease and fatality. Given the breadth of MEDI8852 and other bnAbs, we anticipate that protection from unforeseen pandemic influenza A viruses is achievable.

摘要

甲型流感病毒大流行和季节性流行已夺走无数生命。具有大流行潜力的流感病毒反复出现人畜共患传播,凸显了采取有效应对措施的必要性。在本研究中,我们表明,用广谱中和抗体(bnAb)MEDI8852进行暴露前预防,能非常有效地保护食蟹猴免受雾化高致病性禽流感H5N1病毒感染所致的严重疾病。在所测试的剂量下,保护作用呈抗体剂量依赖性,但与Fc介导的效应功能无关。接受每千克10毫克或更高剂量MEDI8852的猕猴在感染后呼吸功能受损可忽略不计,而对照动物未得到严重疾病和死亡的保护。鉴于MEDI8852和其他bnAb的广谱性,我们预计可以实现对不可预见的甲型流感大流行病毒的保护。

相似文献

1
Pre-exposure antibody prophylaxis protects macaques from severe influenza.暴露前抗体预防可保护猕猴免受严重流感感染。
Science. 2025 Jan 31;387(6733):534-541. doi: 10.1126/science.ado6481. Epub 2025 Jan 30.
2
The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses.血凝素A茎部抗体MEDI8852可预防和控制疾病并限制大流行性流感病毒的传播。
J Infect Dis. 2017 Aug 1;216(3):356-365. doi: 10.1093/infdis/jix292.
3
Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice.中和作用不能预测广谱中和单克隆抗体CR6261和CR9114对小鼠致死性H2流感病毒攻击的预防效果。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01603-17. Print 2017 Dec 15.
4
Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection.单克隆抗体被动免疫在H5N1高致病性禽流感病毒感染动物模型中的保护效力
PLoS Pathog. 2014 Jun 12;10(6):e1004192. doi: 10.1371/journal.ppat.1004192. eCollection 2014 Jun.
5
Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine.一种灭活H5N1全颗粒疫苗对食蟹猴抵御H5N1高致病性禽流感和2009年甲型H1N1流感大流行病毒感染的保护作用。
PLoS One. 2013 Dec 23;8(12):e82740. doi: 10.1371/journal.pone.0082740. eCollection 2013.
6
An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection.一种抗H5N1流感病毒FcDART抗体是一种针对H5N1流感病毒感染的高效治疗剂和预防剂。
J Virol. 2015 Apr;89(8):4549-61. doi: 10.1128/JVI.00078-15. Epub 2015 Feb 11.
7
Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.季节性流感疫苗诱导的异源亚型抗体反应与对高致病性 H5N1 病毒的部分保护作用相关。
PLoS One. 2011 Mar 25;6(3):e17821. doi: 10.1371/journal.pone.0017821.
8
A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.一种由非致病性H5N1禽流感病毒株制备的疫苗可使食蟹猕猴对高致病性禽流感病毒感染产生保护性免疫。
Vaccine. 2008 Jan 24;26(4):562-72. doi: 10.1016/j.vaccine.2007.11.031. Epub 2007 Dec 3.
9
Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques.肺泡中广泛的病毒复制导致猕猴经气溶胶感染H5N1流感后发生急性呼吸窘迫综合征。
J Immunol. 2017 Feb 15;198(4):1616-1626. doi: 10.4049/jimmunol.1601770. Epub 2017 Jan 6.
10
Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.人源单克隆抗体81.39a可有效中和1组和2组血凝素的新型甲型流感病毒。
J Virol. 2016 Nov 14;90(23):10446-10458. doi: 10.1128/JVI.01284-16. Print 2016 Dec 1.

引用本文的文献

1
Therapeutic Antibodies for Infectious Diseases: Recent Past, Present, and Future.用于传染病的治疗性抗体:过去、现在与未来
Biochemistry. 2025 Aug 19;64(16):3487-3494. doi: 10.1021/acs.biochem.5c00192. Epub 2025 Aug 7.
2
Isolation of genetically diverse influenza antibodies highlights the role of IG germline gene variation and informs the design of population-comprehensive vaccine strategies.基因多样化流感抗体的分离突出了IG种系基因变异的作用,并为人群综合疫苗策略的设计提供了信息。
bioRxiv. 2025 Jul 7:2025.07.04.663145. doi: 10.1101/2025.07.04.663145.
3
Highly pathogenic avian influenza: pandemic preparedness for a scenario of high lethality with no vaccines.
高致病性禽流感:在无疫苗情况下应对高致死率疫情的大流行防范措施
Front Public Health. 2025 Jul 16;13:1613869. doi: 10.3389/fpubh.2025.1613869. eCollection 2025.
4
Intranasal administration of a panreactive influenza antibody reveals Fc-independent mode of protection.经鼻内给予泛反应性流感抗体可揭示不依赖Fc的保护模式。
Sci Rep. 2025 Apr 8;15(1):10309. doi: 10.1038/s41598-025-94314-5.